Medications for Chronic Myelomonocytic Leukemia

3 results
  • iclusig - ponatinib hydrochloride tablet, film coated

    (Ponatinib Hydrochloride)
    Takeda Pharmaceuticals America, Inc.
    Iclusig treats adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) — newly diagnosed with chemotherapy or T315I-positive — and chronic myeloid leukemia (CML), including chronic, accelerated, and blast phases, for patients resistant or intolerant to prior kinase inhibitors or with T315I mutation.
  • inqovi - cedazuridine and decitabine tablet, film coated

    (Cedazuridine And Decitabine)
    Taiho Pharmaceutical Co., Ltd.
    INQOVI treats adult patients with myelodysplastic syndromes (MDS) — including refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and CMML — across intermediate-1, intermediate-2, and high-risk IPSS groups, both previously treated and untreated.